⌘K

Login Start Free

Home/Filings/4/0000950170-25-090589

4//SEC Filing

Vieser Jaime 4

Accession 0000950170-25-090589

CIK 0001107421other

View on SEC.gov Company Profile

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 9:22 PM ET

Size

5.4 KB

Accession

0000950170-25-090589

Insider Transaction Report

Form 4

Period: 2025-06-24

Alaunos Therapeutics, Inc.TCRT

Director

Transactions

Purchase
Series A-2 Convertible Preferred Stock
2025-06-24$4.49/sh+250$1,123→ 250 total
Exercise: $4.49From: 2025-06-24→ Common Stock (55,679.29 underlying)

Footnotes (1)

[F1]The preferred stock is perpetual and therefore has no expiration date.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Alaunos Therapeutics, Inc.

CIK 0001107421

Entity typeother

Related Parties

1

filerCIK 0001846045

Filing Metadata

Form type: 4
Filed: Jun 25, 8:00 PM ET
Accepted: Jun 26, 9:22 PM ET
Size: 5.4 KB

View on SEC.gov